Headquarters:
Princeton, NJ
Description:
Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
Categories:
Biotechnology
Website:
http://soligenix.com

Detailed Description

Update

Soligenix, Inc. is a late-stage research and development biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains an unmet medical need, as well as developing biodefense vaccines and therapeutics. The Company maintains two business segments: BioTherapeutics and BioDefense. Its BioTherapeutics business segment focuses to develop oral beclomethasone dipropionate (orBec or oral BDP) and other biotherapeutic products, including LPMTM Leuprolide. Its BioDefense business segment focuses to convert its ricin toxin vaccine and radiation injury program from early stage development to advanced development and manufacturing.

Current Team (2)

Update

Past Team (1)

Update

Funding Rounds (6) - $21.7M

Update

Investors (10)

Update

Offices/Locations (1)

Update
  • Office

    29 Emmons Drive

    Suite C-10

    Princeton, NJ 08540

    USA

Images (1)

Update
  • Ada47f5624d7c14845536e02117b272a